Volume Doubling Times and Outcomes in Stereotactic Ablative Radiotherapy of Early-stage Non-small Cell Lung Cancer

被引:0
|
作者
Chung, M. P. [1 ]
Trakul, N. [1 ]
Le, Q. [1 ]
Hara, W. Y. [1 ]
Dieterich, S. [1 ]
Maxim, P. G. [1 ]
Diehn, M. [1 ]
Loo, B. W. [1 ]
机构
[1] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
D O I
10.1016/j.ijrobp.2011.06.1110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S592 / S592
页数:1
相关论文
共 50 条
  • [1] Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Marar, M.
    Bryant, A. K.
    Nalawade, V.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    Chin, A. L.
    Murphy, J. D.
    Vitzthum, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E447 - E447
  • [2] STEREOTACTIC ABLATIVE RADIOTHERAPY OF EARLY STAGE NON-SMALL CELL LUNG CANCER
    Cvek, Jakub
    Feltl, David
    Knybel, Lukas
    Otahal, Bretislav
    Skacelikova, Eva
    Binarova, Andrea
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S537 - S537
  • [3] Stereotactic ablative radiotherapy and surgery: two gold standards for early-stage non-small cell lung cancer?
    Chen, Hanbo
    Louie, Alexander V.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (09)
  • [4] Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea
    Song, Sanghyuk
    Chang, Ji Hyun
    Kim, Hak Jae
    Kim, Yeon Sil
    Kim, Jin Hee
    Ahn, Yong Chan
    Kim, Jae-Sung
    Song, Si Yeol
    Moon, Sung Ho
    Cho, Moon June
    Youn, Seon Min
    [J]. CANCER RESEARCH AND TREATMENT, 2017, 49 (03): : 688 - 694
  • [5] Prognostic factors for control of early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
    Charlton, Thomas
    Hindocha, Sumeet
    Hanumanthappa, Nikesh
    Smith, Daniel
    Vivekanandan, Sindu
    Taylor, Benjamin
    Skwarski, Michael
    Ahmad, Shahreen
    [J]. LUNG CANCER, 2021, 156 : S60 - S61
  • [6] Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a word of caution
    Varela, Gonzalo
    Teresa Gomez-Hernandez, Maria
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 102 - 105
  • [7] Treatment of Early Stage Non-Small Cell Lung Cancer: Surgery or Stereotactic Ablative Radiotherapy?
    Uzel, Esengul Kocak
    Abacioglu, Ufuk
    [J]. BALKAN MEDICAL JOURNAL, 2015, 32 (01) : 8 - 16
  • [8] Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
    Jacobs, Corbin D.
    Mehta, Kurren
    Gao, Junheng
    Wang, Xiaofei
    Salama, Joseph K.
    Kelsey, Chris R.
    Torok, Jordan A.
    [J]. CLINICAL LUNG CANCER, 2022, 23 (02) : 177 - 184
  • [9] The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
    Dahele, Max
    Senan, Suresh
    [J]. CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 75 - 82
  • [10] Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
    Beal, J.
    Gomes, D.
    Taranto, P.
    Koch, L.
    Rezende, A. C.
    Samano, M.
    Bibas, B.
    Gomes, O.
    Campregher, P.
    Severino, P.
    Marti, L.
    Paes, V.
    Chate, R.
    Sales, D.
    Schvartsman, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S652